Nomelcitinib

Nomelcitinib is a TYK2 inhibitor that modulates the IL23 signaling pathway. Nomelcitinib is used for research on multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, psoriasis, psoriatic arthritis, Crohn's disease, Sjögren's syndrome, and scleroderma.

For research use only. We do not sell to patients.

  • CAS No.: 2794195-73-4
  • Formula: C16H14D3ClN6O4S
  • Molecular Weight:427.88
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg
Get Quote In-stock
Please select quantity
Price: USD 0.00